Literature DB >> 878467

The treatment of the nephritis of lupus erythematosus.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 878467      PMCID: PMC1237635     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  19 in total

1.  THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  V E POLLAK; C L PIRANI; F D SCHWARTZ
Journal:  J Lab Clin Med       Date:  1964-04

2.  A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.

Authors:  A D Steinberg; J L Decker
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

3.  Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.

Authors:  W J Fessel
Journal:  Arch Intern Med       Date:  1974-12

4.  The clinical course of lupus nephritis: relationship to the renal histologic findings.

Authors:  V E Pollak; C L Pirani; I Dujovne; M G Dillard
Journal:  Perspect Nephrol Hypertens       Date:  1973

5.  Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.

Authors:  J V Donadio; K E Holley; R D Wagoner; R H Ferguson; F C McDuffie
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

6.  Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965.

Authors:  M Siegel; H L Holley; S L Lee
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

7.  Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.

Authors:  J L Decker; J H Klippel; P H Plotz; A D Steinberg
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

8.  Treatment of lupus nephritis with cyclophosphamide.

Authors:  J S Cameron; M Boulton-Jones; R Robinson; C Ogg
Journal:  Lancet       Date:  1970-10-24       Impact factor: 79.321

9.  Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis.

Authors:  E S Cathcart; B A Idelson; M A Scheinberg; W G Couser
Journal:  Lancet       Date:  1976-01-24       Impact factor: 79.321

10.  The clinical course of the proliferative and membranous forms of lupus nephritis.

Authors:  D S Baldwin; J Lowenstein; N F Rothfield; G Gallo; R T McCluskey
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

View more
  1 in total

1.  New approaches to treating systemic lupus erythematosus.

Authors:  D Wofsy
Journal:  West J Med       Date:  1987-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.